Answers are grounded in this paper and cite their sources.
Demonstrates the enhanced sustained-release of pregabalin co-crystals in drug formulation, suggesting improved management of neuropathic pain.
Abstract:Pregabalin, as an analgesic drug, can treat epilepsy and neuropathic pain. However, it suffers from short half-life and rapid metabolism. In this work, crystal engineering strategy was employed to regulate...
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: